PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12224020-3 2002 We reported that an adenoviral vector containing wt p53 significantly reduced [(3)H]thymidine uptake in melanoma cells containing mutant but not wt p53. Thymidine 84-93 tumor protein p53 Homo sapiens 52-55 14695155-2 2003 Importantly, the cytotoxic effects of thymidine deprivation induced by 5-fluorouracil (FUra) combined with leucovorin (LV) was enhanced by IFN-gamma, and the synergism was shown to be dependent on Fas, FUra-induced DNA damage, and independent of p53. Thymidine 38-47 tumor protein p53 Homo sapiens 246-249 15647429-10 2005 Chondrocyte [(3)H]thymidine uptake correlated positively with Bcl-2 (r(s) = 0.62, p = 0.009) and correlated inversely with p53 levels (r(s) = -0.55, p = 0.02). Thymidine 18-27 tumor protein p53 Homo sapiens 123-126 12782403-5 2003 Pre-transfection of cultured hepatoma cells with p53mt249 resulted in a three to fourfold increase in IGF-IR phosphorylation and downstream mediator IRS-I phosphorylation but, enhanced more than 15-fold after IGF-II treatment, which coincides well with the cell growth and thymidine uptake results. Thymidine 273-282 tumor protein p53 Homo sapiens 49-52 9468185-5 1998 p53 gene transfer reduced thymidine incorporation of VSMCs stimulated by platelet-derived growth factor-BB (P<.001). Thymidine 26-35 tumor protein p53 Homo sapiens 0-3 10226585-4 1999 Furthermore, 3H-thymidine incorporation in KOSC-3 cells, which display the p53 gene mutation, was inhibited by protons much more than by gamma-rays. Thymidine 16-25 tumor protein p53 Homo sapiens 75-78 11980662-9 2002 Both inducible TS expression and the addition of exogenous thymidine (10 microM) blocked p53 and p21 induction by the antifolates but not by 5-FU in the M7TS90 cell line. Thymidine 59-68 tumor protein p53 Homo sapiens 89-92 10421546-6 1999 The functional status of p53 in cells was assessed by thymidine and BrdU incorporation following exposure to ionizing radiation (4 Gy). Thymidine 54-63 tumor protein p53 Homo sapiens 25-28 9607592-3 1998 The sensitization ratio due to the transfected wt p53 varied from about 2-fold for cisplatin to over 50-fold for thymidine. Thymidine 113-122 tumor protein p53 Homo sapiens 50-53 8774641-10 1996 The growth of the Ad5CMV-p53-infected cells was greatly suppressed as detected by both cell count and [3H]thymidine incorporation assay. Thymidine 106-115 tumor protein p53 Homo sapiens 25-28 8668331-0 1996 Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Thymidine 39-48 tumor protein p53 Homo sapiens 91-94 8668331-0 1996 Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Thymidine 39-48 tumor protein p53 Homo sapiens 99-102 9816160-8 1996 Conversely, the hazard increased with the increase of p53-positive cells only for tumors with a [3H]dT LI lower than 7.5%. Thymidine 100-102 tumor protein p53 Homo sapiens 54-57 8886839-7 1996 In vitro studies showed that cell growth, as measured by the thymidine incorporation assay, was inhibited in the C4-2, PC-3, and DU145 cells infected with wild-type p53 adenovirus in comparison to control viruses. Thymidine 61-70 tumor protein p53 Homo sapiens 165-168 8979269-6 1996 A253-p53 cells could be distinguished from native A253 cells by prolonged doubling times (2-5 fold) and by a marked reduction of [3H]-thymidine uptake. Thymidine 134-143 tumor protein p53 Homo sapiens 5-8 9552394-4 1996 In this article we review some of the emerging data that suggests the role of p53 in determining whether the cellular response to dThd deprivation is cytostasis or cytotoxicity (apoptosis). Thymidine 130-134 tumor protein p53 Homo sapiens 78-81 18850315-6 2008 Transfection of HUVEC with dominant negative p53 cDNA prevented the progesterone-induced increases in p21 and p27 promoter activity and protein level, decreases in thymidine incorporation, and capillary-like tube formation. Thymidine 164-173 tumor protein p53 Homo sapiens 45-48 1873816-7 1991 Immunocytochemical data indicate that prostate carcinoma cells expressing the transfected wild-type p53 gene are growth arrested because they exhibit a reduced level of thymidine incorporation into DNA. Thymidine 169-178 tumor protein p53 Homo sapiens 100-103 7560890-3 1995 In breast cancer, we observed a poor correlation (rs = 0.17) between P53 expression and proliferative activity evaluated as [3H]-thymidine ([3H]-dT) labeling index and an independent prognostic relevance of the two variables. Thymidine 129-138 tumor protein p53 Homo sapiens 69-72 7560890-3 1995 In breast cancer, we observed a poor correlation (rs = 0.17) between P53 expression and proliferative activity evaluated as [3H]-thymidine ([3H]-dT) labeling index and an independent prognostic relevance of the two variables. Thymidine 145-147 tumor protein p53 Homo sapiens 69-72 7560890-7 1995 A weak direct relation between P53 positivity and [3H]-dT incorporation (rs = 0.4) was observed on the overall series of P53+ tumors and was maintained in subgroups defined by several biological and pathological features, except for estrogen receptor-negative tumors. Thymidine 55-57 tumor protein p53 Homo sapiens 31-34 7560890-7 1995 A weak direct relation between P53 positivity and [3H]-dT incorporation (rs = 0.4) was observed on the overall series of P53+ tumors and was maintained in subgroups defined by several biological and pathological features, except for estrogen receptor-negative tumors. Thymidine 55-57 tumor protein p53 Homo sapiens 121-124 7616356-8 1995 Tumours with p53 gene mutations at exon 5 had a higher median [3H]thymidine labelling index (17 per cent) than those with mutations at exons 6, 7, and 8 (11.8 per cent). Thymidine 66-75 tumor protein p53 Homo sapiens 13-16 7627557-2 1995 We have examined potential p53-mediated effects of metabolically labeling cultured mammalian cells with [35S]methionine and [3H]thymidine, methods that are commonly used to study the biochemical properties, synthesis, processing and degradation of proteins and the replication of DNA in proliferating cells. Thymidine 128-137 tumor protein p53 Homo sapiens 27-30 1322785-5 1992 Furthermore, the incorporation of thymidine into DNA was reduced in cancer cells expressing the wild-type p53 gene. Thymidine 34-43 tumor protein p53 Homo sapiens 106-109 25401976-8 2015 Furthermore, inhibition of Fhit loss-induced DNA damage via thymidine supplementation decreases the TP53 mutation burden in FHIT-low/APOBEC3B-high cells. Thymidine 60-69 tumor protein p53 Homo sapiens 100-104